Angiodynamics to report fiscal 2025 fourth quarter and full-year financial results on tuesday, july 15, 2025

Latham, n.y.--(business wire)--angiodynamics, inc. (nasdaq: ango), a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient quality of life, today announced that it will report financial results for the fourth quarter and fiscal year 2025 before the market open on tuesday, july 15, 2025. the company's management will host a conference call at 8:00 am et the same day to.
ANGO Ratings Summary
ANGO Quant Ranking